New feature highlights for Geneious Biologics include Analysis Workflows for batching NGS Antibody Annotation, a Most Common Representative Sequence option, interactive graphs with colorblind-friendly palettes, and more.
New feature highlights for Geneious Biologics include cluster relationships visualization, assay data heat maps for circular trees and other improvements.
New feature highlights for Geneious Biologics include support for non-antibody therapeutic peptides and the ability to share your analysis options with your team.
Exciting new features for Geneious Biologics include manual sequence editing, dual nanobody (VHH-VHH) support, and protein scaffold reference databases.
In Q2 2021 we have focused on improving visualizations and overall usability in Geneious Biologics. Highlights include Graph Usability Improvements, Moveable Folders, and REST API.
Geneious Biologics has introduced Searchable Collections to save curated lists of annotated antibody sequences, complete with assay data and other relevant sequence information.
Multi-region alignment improvements are now available in Geneious Biologics allowing you to align multiple regions at once, directly from the "All Sequences" result table.
We have recently released a number of features and improvements to Geneious Biologics including dynamic reporting, automated sequence repair and upload improvements.
Geneious Biologics has added new functionality designed to improve workflows for biologic drug development including visualizing similarity clusters in alignments, quickly summarizing families of sequences with sequence logos, and Unique Molecular Identifier (UMI) processing.